|
ACXP Acurx Pharmaceuticals Inc 1736243 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,254,173.00 |
| Balance Sheet |
|
Current Assets
|
$6,157,858.00 |
|
Assets
|
$10,984,777.00 |
|
Current Liabilities
|
$2,832,746.00 |
|
Liabilities
|
$2,832,746.00 |
|
Equity
|
$8,152,031.00 |
|
Shares Out
|
4683253.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,117,485.00 |
| Market Analysis |
Market Cap
|
$6,790,716.85 |
|
Price
|
$1.39 |
|
BVPS
|
1.74 |
|
PB
|
0.83 |
|
EPS
|
-0.53 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
| Apr |
May |
Jun |
| 2026-03-13 |
-0.73 |
|
|
2026-05-12 |
-0.62 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-1.89 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-1.23 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACXP documents filed with the SEC.
ACXP Filings
Clear
